Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Biliary Tract Neoplasms × spartalizumab × 1 year × Clear all

Sponsor

Conditions

Melanoma 9 Carcinoma, Non-Small-Cell Lung 7 Pancreatic Neoplasms 6 Colorectal Neoplasms 6 Stomach Neoplasms 5 Carcinoma, Renal Cell 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Nasopharyngeal Carcinoma 4 Neoplasm Metastasis 3 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Solid Tumors 2 Solid Tumor 2 Skin Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Myelodysplastic Syndromes 2 Lung Neoplasms 2 Locally Advanced Rectal Cancer 2 Leukemia, Myelomonocytic, Chronic 2 Glioblastoma 2 Esophageal Squamous Cell Carcinoma 2 Breast Neoplasms 2 Advanced Solid Tumors 2 von Hippel-Lindau Disease 1 Thyroid cancer, follicular 1 Thyroid cancer, Hurthle cell 1

Interventions

Gemcitabine 29 Cisplatin 28 durvalumab 17 pembrolizumab 13 Leucovorin 11 Oxaliplatin 10 Fluorouracil 9 Capecitabine 9 Nivolumab 8 lenvatinib 7 Bevacizumab 6 zanidatamab 4 Liquid Biopsy 4 Folfox protocol 4 Carboplatin 4 130-nm albumin-bound paclitaxel 4 tremelimumab 3 tislelizumab 3 irinotecan sucrosofate 3 Trastuzumab 3 S 1 (combination) 3 Injections 3 pertuzumab 2 niraparib 2 ivosidenib 2 gemcitabine-oxaliplatin regimen 2 envafolimab 2 brigimadlin 2 atezolizumab 2 Tegafur 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡